1. Home
  2. HAS vs ITRM Comparison

HAS vs ITRM Comparison

Compare HAS & ITRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hasbro Inc.

HAS

Hasbro Inc.

HOLD

Current Price

$87.23

Market Cap

11.1B

ML Signal

HOLD

Logo Iterum Therapeutics plc

ITRM

Iterum Therapeutics plc

HOLD

Current Price

$0.36

Market Cap

24.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HAS
ITRM
Founded
1923
2015
Country
United States
Ireland
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.1B
24.3M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
HAS
ITRM
Price
$87.23
$0.36
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
11
1
Target Price
$88.55
$9.00
AVG Volume (30 Days)
1.5M
919.6K
Earning Date
02-19-2026
02-06-2026
Dividend Yield
3.21%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,357,000,000.00
$390,000.00
Revenue This Year
$10.24
N/A
Revenue Next Year
$5.62
$193.01
P/E Ratio
N/A
N/A
Revenue Growth
0.79
N/A
52 Week Low
$49.00
$0.26
52 Week High
$87.38
$2.10

Technical Indicators

Market Signals
Indicator
HAS
ITRM
Relative Strength Index (RSI) 71.52 45.05
Support Level $81.65 $0.26
Resistance Level $82.98 $0.37
Average True Range (ATR) 1.48 0.04
MACD 0.44 0.01
Stochastic Oscillator 87.92 65.61

Price Performance

Historical Comparison
HAS
ITRM

About HAS Hasbro Inc.

Hasbro is a branded play company providing children and families around the world with entertainment offerings based on a world-class brand portfolio. From toys and games to television programming, motion pictures, and a licensing program, Hasbro reaches customers by leveraging its well-known brands such as Transformers, Nerf, and Magic: The Gathering. The firm acquired EOne in 2019, bolting on popular family properties like Peppa Pig and PJ Masks, and since has divested noncore lines from the tie-up. Furthermore, the addition of Dungeons & Dragons Beyond in 2022, offers the firm access to 19 million digital tabletop players.

About ITRM Iterum Therapeutics plc

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.

Share on Social Networks: